Search
for
Sort by
Research 211–240 of 1000+
- Understanding Polycystic Ovary Syndrome
- The Rotterdam Study: 2016 objectives and design update
- In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Understanding Microemulsions and Nanoemulsions in (Trans)Dermal Delivery
- Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
- Scalpel, Toxin, and Performance Pressure: Metabolic, Psychiatric, and Psychosocial Aspects of Aesthetic Medicine in Competitive and Physique Athletes
- Herbal Approaches for the Management of Premature Hair Greying: Mechanisms, Phytoconstituents and Delivery Strategies
- The modern scientific interpretation of ancient wisdom: a review of the phytochemistry and pharmacology of Erzhi Pill and its constituent botanical drugs
- Comparing minoxidil-finasteride mixed solution with minoxidil solution alone for male androgenetic alopecia: a systematic review and meta-analysis of randomized controlled trials
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Absorption sites of orally administered drugs in the small intestine
- A novel therapeutic paradigm for patients with extensive alopecia areata
- The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Effects of Oral Contraceptives Containing Desogestrel and Drospirenone on Clinical, Hormonal, and Metabolic Parameters of the Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- The role of androgens in hormone replacement therapy
- Niosomes as a propitious carrier for topical drug delivery
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Hemodynamic effects of minoxidil following intravenous infusions in untreated hypertensive patients.
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
- Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia
- Advancing mitochondrial therapeutics: Synthesis and pharmacological evaluation of pyrazole-based inhibitors targeting the mitochondrial pyruvate carrier
- Design of Nanocrystalline Suspension of Dutasteride for Intramuscular Prolonged Delivery
- Sulfasalazine for alopecia areata
- Induction of ferroptosis by natural products in non-small cell lung cancer: a comprehensive systematic review
- Review of systemic methotrexate therapy in pediatric dermatoses